View drug registration information details.
Items | Registration information |
ID | 1695 |
No | 1695 |
Brand Name | LUCIBOSE |
Ingredients | COBIMETINIB 20 MG |
Dosage Form | TABLET |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 63'S/BOTTLE |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | FOR THE TREATMENT OF ADULT PATIENTS WITH UNRESECTABLE OR METASTATIC MELANOMA WITH A BRAF V600E OR V600K MUTATION, INCOMBINATION WITH VEMURAFENIB, AS A SINGLE AGENT FOR THE TREATMENT OF ADULT PATIENTS WITH HISTIOCYTIC NEOPLASMS |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE TABLET |
Note | |
License Owner | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Manufacturer | LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 03 L 1317/25 |
FDD Registration Date | 07-APR-2025 |
Expiry Date | 06-APR-2030 |
Back to drug list
|